Related by context. Frequent words. (Click for all words.) 65 Kiadis Pharma 64 Preclinical Development 63 Regado Biosciences 63 Simon Sturge 62 Æterna Zentaris 62 Arthur S. Przybyl 62 Agile Therapeutics 62 Gilles Gagnon 61 NASDAQ IPXL today 61 Onno van de Stolpe 61 Paris IPN 60 Edward Lanphier Sangamo 60 Dr. Axel Herberg 60 ExonHit Therapeutics 60 J. Donald deBethizy 60 ANAVEX 60 Emisphere Technologies 60 Trophos 60 Brian JG Pereira 60 Sol J. Barer 60 Dino Dina 59 Genaera Corporation 59 Diatos 59 Michael H. Tardugno 59 Steven A. Kriegsman 59 Patient Enrollment 59 Franz B. Humer 59 Idera Pharmaceuticals 59 Response Genetics 59 PregLem 59 Metabasis Therapeutics Inc. 59 Aegerion 59 Flamel Technologies 59 Pyng Medical 59 NASDAQ SCLN 59 ImmunoCellular Therapeutics 58 Taligen 58 Impax Pharmaceuticals 58 Dynogen 58 Daniel Von Hoff 58 Paladin Labs 58 Jean Paul Clozel 58 Jeffrey H. Buchalter 58 CardioVascular BioTherapeutics Inc. 58 Santhera 58 Applied NeuroSolutions 58 Helix BioPharma 58 Matthew Emmens 58 Discusses Q3 58 XTENT 58 Quark Pharmaceuticals 58 Initiates Phase II 58 Gentium 58 Cempra 58 Therapeutic Competitors 58 PsychoGenics 58 Sunesis Pharmaceuticals 57 Inc Therapeutic Competitors 57 MultiCell Technologies 57 Regulus Therapeutics 57 ESBATech 57 Intendis 57 OncoGenex Pharmaceuticals 57 NASDAQ IMCL 57 Fero Industries Inc. 57 Nanobiotix 57 Nasdaq ADLR 57 Receives Orphan Drug Designation 57 Dr. Joseph Feczko 57 Inovio Pharmaceuticals 57 Ligand Pharmaceuticals Incorporated 57 Cerus Corporation 57 EKR Therapeutics 57 Chemokine Therapeutics 57 SCOLR Pharma 57 Sirona Biochem 57 NicOx 57 Inc. Nasdaq SEPR 57 Jack Lief 57 Ore Pharmaceuticals 57 ACADIA Pharmaceuticals 57 SciClone Pharmaceuticals 57 ProtoKinetix 57 huC# DM4 57 Marc Cluzel 57 Neogenix Oncology 57 Addex Pharmaceuticals 57 Tranzyme Pharma 57 QuatRx 57 GSK Biologicals 56 Walt Woltosz chairman 56 Paul F. Matysek 56 Vicor Technologies 56 HepaLife Technologies Inc. 56 DSM Biomedical 56 Evotec AG 56 MacuSight 56 NOXXON 56 Vaccinex 56 AltheaDx 56 Relypsa